The Maryland program’s spending on both obesity drugs grew 86% year-over-year, Real Chemistry said, the seventh highest in ...

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

Obesity dipped slightly in U.S. adults last year, research found — the first time in more than a decade that the country has ...

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

Ozempic is synonymous with weight loss for many people, even as they can turn to drugs with other brand names that have been ...

Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.

MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.